A consensus statement on the use of botulinum toxin in pediatric patients.

Document Type

Article

Publication Date

9-2022

Identifier

DOI: 10.1002/pmrj.12713

Abstract

Botulinum toxin has been used in medicine for the past 30 years. However, there continues to be controversy about the appropriate uses and dosing, especially in the pediatric population. A panel of nine pediatric physiatrists from different regions and previous training programs in the United States were nominated based on institutional reputation and botulinum toxin (BoNT) experience. Based on a review of the current literature, the goal was to provide the rationale for recommendations on the administration of BoNT in the pediatric population. The goal was not only to review safety, dosing, and injection techniques but also to develop a consensus on the appropriate uses in the pediatric population. In addition to upper and lower limb spasticity, the consensus also provides recommendations for congenital muscular torticollis, cervical dystonia, sialorrhea, and brachial plexus palsies.

Journal Title

PM R

Volume

14

Issue

9

First Page

1116

Last Page

1142

MeSH Keywords

Botulinum Toxins, Type A; Child; Consensus; Humans; Muscle Spasticity; Neuromuscular Agents; Physiatrists; Torticollis; Treatment Outcome

Keywords

Botulinum Toxins, Type A; Consensus; Muscle Spasticity; Neuromuscular Agents; Physiatrists; Torticollis; Treatment Outcome

Link to Full Text
Library Record

Share

COinS